Joong‐Won Park - Researcher Profile

Publications

2 shown

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

Masatoshi Kudo , Richard S. Finn , Shukui Qin +19 more

2018 The Lancet 5118 citations

Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

Ghassan K. Abou‐Alfa , Tim Meyer , Ann‐Lii Cheng +19 more

Among patients with previously treated advanced hepatocellular carcinoma, treatment with cabozantinib resulted in longer overall survival and progression-free survival than plac...

2018 New England Journal of Medicine 2228 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 7,346
Institution: National Cancer Center

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-9972-0494

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.